Trials / Recruiting
RecruitingNCT07230483
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
An Open-Label, Multicenter Study to Evaluate Long-Term Safety and Efficacy of CM512 in Atopic Dermatitis Patients.
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 246 (estimated)
- Sponsor
- Keymed Biosciences Co.Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an Open-label ,Multicenter Study to evaluate Long-Term Safety and Efficacy of CM512 in patients with Atopic Dermatitis who have completed treatment in parent CM512 Study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CM512 | CM512 subcutaneous injection |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2025-11-17
- Last updated
- 2025-11-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07230483. Inclusion in this directory is not an endorsement.